ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • Clin Pharmacol Biopharm 2023, Vol 12(7): 360
  • DOI: 10.4172/2167-065X.1000360

The Promising Potential of Targeted Drug Therapies: Revolutionizing Treatment Approaches

Philip Dorel*
Department of Clinical Diabetes, Bahrain
*Corresponding Author : Philip Dorel, Department of Clinical Diabetes, Bahrain, Email: Philip_d19@gmail.com

Received Date: Jul 03, 2023 / Published Date: Jul 28, 2023

Citation: Dorel P (2023) The Promising Potential of Targeted Drug Therapies: Revolutionizing Treatment Approaches. Clin Pharmacol Biopharm, 12: 360. Doi: 10.4172/2167-065X.1000360

Copyright: © 2023 Dorel P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top